Literature DB >> 27738364

Long Acting Risperidone in an Adolescent with Conduct Disorder: A Case Report.

Mustafa Deniz Tutkunkardaş1, Osman Abali1.   

Abstract

Adolescent conduct disorder (CD) is generally hard to manage clinically, as this population often refuses to take oral medications. Families and acquaintances of these adolescents usually suffer from extreme psychological, financial and social difficulties. Oral antipsychotics are the primary drugs of choice clinically, after behavioral treatments. Here we report a case with attention deficit hyperactivity disorder and conduct disorder who refuses to take any medications, was not eligible for behavioral treatments and was treated successfully with long acting risperidone.

Entities:  

Keywords:  Adolescence; Attention Deficit Hyperactivity Disorder; Conduct Disorder; Medication Noncompliance; Risperidone

Year:  2011        PMID: 27738364      PMCID: PMC5044551     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  5 in total

Review 1.  Attention deficit disorder during adolescence: a review.

Authors:  H C Faigel; S Sznajderman; O Tishby; M Turel; U Pinus
Journal:  J Adolesc Health       Date:  1995-03       Impact factor: 5.012

2.  Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

Authors:  D Thiruchelvam; A Charach; R J Schachar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-08       Impact factor: 8.829

Review 3.  Risperidone in the management of disruptive behavior disorders.

Authors:  Gahan J Pandina; Michael G Aman; Robert L Findling
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-08       Impact factor: 2.576

Review 4.  Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.

Authors:  Robert L Findling
Journal:  J Clin Psychiatry       Date:  2008       Impact factor: 4.384

5.  Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Authors:  Robin Emsley; Petrus Oosthuizen; Liezl Koen; Dana J H Niehaus; Rossella Medori; Jonathan Rabinowitz
Journal:  Clin Ther       Date:  2008-12       Impact factor: 3.393

  5 in total
  2 in total

1.  Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting.

Authors:  Ulku Akyol Ardic; Mustafa Küçükköse; Sevim Berrin Inci; Eyüp Sabri Ercan
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-02-28       Impact factor: 2.582

2.  A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder.

Authors:  Sevcan Karakoç Demirkaya; Hatice Aksu; Börte Gürbüz Özgür
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.